Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
about
The clinical efficacy of artemether/lumefantrine (Coartem)Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, LiberiaCombining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials.Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study.Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed?Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved ToolPopulation pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrineMalaria: an update on current chemotherapy.Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan childrenFixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic reviewRandomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire.Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impactThe global pipeline of new medicines for the control and elimination of malariaTherapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study.Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, AngolaArtesunate Plus Amodiaquine (AS+AQ) Versus Artemether -Lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Sub-Saharan Africa-A Meta-AnalysisTherapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana.Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana.Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and SeFactors influencing adverse events reporting within the health care system: the case of artemisinin-based combination treatments in northern Ghana.Reversible audiometric threshold changes in children with uncomplicated malariaArtesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children.Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.Safety profile of Coartem: the evidence base.Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria.Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.
P2860
Q21034141-9DCA16AF-1E4B-474E-9A1F-BA41755D0540Q28691509-93A6C86B-C1F3-4725-A682-DC35F30F3D20Q30567158-76800D7E-0333-49ED-9AAC-B8A6C4E6BA11Q33399342-D02317DA-B4F3-410F-89AC-18C43F337620Q33605684-C40843D7-C082-4C1E-ABF3-980BDF30F4ACQ33635019-C2B4A50C-54EF-4358-B40E-B4A927289581Q33686633-D5321345-3A35-4F34-80C4-EFA967830D32Q33806574-8830A354-7F1F-4BC2-89D8-5BF59C99F426Q33841142-E0D5FF16-5E13-463C-A4D1-7F8406AB3EB0Q33875677-03947999-174D-4FDD-895E-2173289504EBQ33876535-CAA9DD61-5A98-4799-850D-5ECD5B5071A6Q34221884-D21C0F47-5496-4DDB-B83D-E7BFD85F09C0Q34433106-9E5164F3-1C3B-4222-87DA-C6995E4D0C2FQ34600201-E985FECF-7768-4069-9390-D3E13FE1E198Q34996451-6EFCF660-695B-4A91-9C55-49FE2137E061Q35029488-84FD008C-3C08-48E0-9996-F8ADDCF48076Q35052961-11FA9BD6-BFB9-4A0F-BF51-9341EBF00C06Q35154559-58775287-F6A8-4899-B6C4-48ABE5A511A7Q35245962-BA02091A-5EA9-448A-A2D1-12D515B0CAF6Q35996318-239D316A-8927-4744-A875-F524070E5C7BQ36080127-95BE0B29-642E-4D1C-92F2-D87A92EBCECBQ36320249-F132AC15-32DB-4632-AFE8-07C8B0A58546Q36334960-96082201-A9B5-4A7A-9C92-DBCD5C6DEEBCQ36376796-DC677EE0-1D7E-4D71-B361-93229895A304Q36398146-1968317E-F5E2-4051-8D2E-C510FFE84885Q36428340-F5085208-72CB-4B96-A693-EC7E2DDC51B5Q36459535-96BE3E61-3F40-43B8-BCF6-C6B1B0F29B63Q36507484-7B6276E5-6588-4AFF-9844-8F9DD7C7D3E7Q36531316-5048C0B7-2A3A-4E3C-8118-038CC81A910EQ36625627-799DAC7F-FAEE-47FF-8298-C1C63B3B194CQ36711788-A863C76D-8360-4A93-BC6D-0F2C35D4E718Q36812874-264E6AA9-2FF8-48F8-867C-B44BCC4AACBAQ36993430-6F3922CA-3618-4C33-AD5C-CA082ED79DAEQ37059334-8EF36F43-72D9-4958-A2CA-E08DD0DB5331Q37333155-D4653A3C-E12C-49C1-9481-0E6634DB96F7Q37349030-3FDC13D9-51E6-4B66-8E53-C31ED33B08CBQ37383298-EE927F34-9F3B-447A-BE78-B4B5F013ED2CQ37388596-209B039F-B540-4F83-801E-7496928E296EQ37579921-6804B513-69C0-4678-BD06-EFE2ABDD9915Q37857327-1183BEEE-3585-44FD-8FBB-3AE273A15426
P2860
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Amodiaquine-artesunate vs arte ...... trial with one year follow-up.
@en
type
label
Amodiaquine-artesunate vs arte ...... trial with one year follow-up.
@en
prefLabel
Amodiaquine-artesunate vs arte ...... trial with one year follow-up.
@en
P2093
P2860
P921
P356
P1433
P1476
Amodiaquine-artesunate vs arte ...... trial with one year follow-up
@en
P2093
Bamenla Q Goka
Ebenezer V Badoe
Emmanuel D Kitcher
George O Adjei
Lotte C G Hoegberg
Onike P Rodrigues
Roberta Lamptey
P2860
P2888
P356
10.1186/1475-2875-7-127
P577
2008-07-11T00:00:00Z
P5875
P6179
1028127283